Literature DB >> 22245800

Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases.

Angelia D Lockett1, Mary Van Demark, Yuan Gu, Kelly S Schweitzer, Ninotchka Sigua, Krzysztof Kamocki, Iwona Fijalkowska, Jana Garrison, Amanda J Fisher, Karina Serban, Robert A Wise, Terence R Flotte, Christian Mueller, Robert G Presson, Horia I Petrache, Rubin M Tuder, Irina Petrache.   

Abstract

α-1 Antitrypsin (A1AT) is a serpin with a major protective effect against cigarette smoke-induced emphysema development, and patients with mutations of the A1AT gene display a markedly increased risk for developing emphysema. We reported that A1AT protects lung endothelial cells from apoptosis and inhibits caspase-3 activity. It is not clear if cigarette smoking or A1AT mutations alter the caspase-3 inhibitory activity of A1AT and if this serpin alters the function of other caspases. We tested the hypothesis that the caspase-3 inhibitory activity of A1AT is impaired by cigarette smoking and that the A1AT RCL, the key antiprotease domain of the serpin, is required for its interaction with the caspase. We examined the caspase-3 inhibitory activity of human A1AT purified from plasma of actively smoking and nonsmoking individuals, either affected or unaffected with chronic obstructive pulmonary disease. We also tested the caspase inhibitory activity of two mutant forms of A1AT, the recombinant human piZZ and the RCL-deleted (RCL-null) A1AT forms. A1AT purified from the blood of active smokers exhibited marked attenuation in its caspase-3 inhibitory activity, independent of disease status. In vitro exposure of the normal (MM) form of A1AT to cigarette smoke extract reduced its ability to interact with caspase-3, measured by isothermal titration calorimetry, as did the deletion of the RCL, but not the ZZ point mutation. In cell-free assays A1AT was capable of inhibiting all executioner caspases, -3, -7 and especially -6, but not the initiator or inflammatory caspases. The inhibitory effect of A1AT against caspase-6 was tested in vivo, where overexpression of both human MM and ZZ-A1AT via adeno-associated virus transduction significantly protected against apoptosis and against airspace damage induced by intratracheal instillation of caspase-6 in mice. These data indicate a specific inhibitory effect of A1AT on executioner caspases, which is profoundly attenuated by active exposure to cigarette smoking and is dependent on the protein RCL, but is not affected by the PiZZ mutation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245800      PMCID: PMC3356416          DOI: 10.2119/molmed.2011.00207

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  35 in total

Review 1.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

2.  Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema.

Authors:  P R Elliott; D Bilton; D A Lomas
Journal:  Am J Respir Cell Mol Biol       Date:  1998-05       Impact factor: 6.914

3.  Deaths: preliminary data for 2009.

Authors:  Kenneth D Kochanek; Jiaquan Xu; Sherry L Murphy; Arialdi M Miniño; Hsiang-Ching Kung
Journal:  Natl Vital Stat Rep       Date:  2011-03

4.  Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury.

Authors:  Stefano Toldo; Ignacio M Seropian; Eleonora Mezzaroma; Benjamin W Van Tassell; Fadi N Salloum; Eli C Lewis; Norbert Voelkel; Charles A Dinarello; Antonio Abbate
Journal:  J Mol Cell Cardiol       Date:  2011-05-12       Impact factor: 5.000

5.  Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.

Authors:  S Song; J Embury; P J Laipis; K I Berns; J M Crawford; T R Flotte
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

6.  Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice.

Authors:  Irina Petrache; Viswanathan Natarajan; Lijie Zhen; Terry R Medler; Amy T Richter; Chung Cho; Walter C Hubbard; Evgeny V Berdyshev; Rubin M Tuder
Journal:  Nat Med       Date:  2005-04-24       Impact factor: 53.440

7.  Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity.

Authors:  C Taggart; D Cervantes-Laurean; G Kim; N G McElvaney; N Wehr; J Moss; R L Levine
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

8.  Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants.

Authors:  B Bartalesi; E Cavarra; S Fineschi; M Lucattelli; B Lunghi; P A Martorana; G Lungarella
Journal:  Eur Respir J       Date:  2005-01       Impact factor: 16.671

9.  Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema.

Authors:  Naoko Yokohori; Kazutetsu Aoshiba; Atsushi Nagai
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

10.  A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema.

Authors:  Irina Petrache; Iwona Fijalkowska; Lijie Zhen; Terry R Medler; Emile Brown; Pedro Cruz; Kang-Hyeon Choe; Laimute Taraseviciene-Stewart; Robertas Scerbavicius; Lee Shapiro; Bing Zhang; Sihong Song; Dan Hicklin; Norbert F Voelkel; Terence Flotte; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2006-03-02       Impact factor: 21.405

View more
  22 in total

Review 1.  Engineering the serpin α1 -antitrypsin: A diversity of goals and techniques.

Authors:  Benjamin M Scott; William P Sheffield
Journal:  Protein Sci       Date:  2019-12-09       Impact factor: 6.725

Review 2.  The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Heidi Villalba; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2020-10-08       Impact factor: 4.030

3.  Alpha 1-antitrypsin ameliorates ventilator-induced lung injury in rats by inhibiting inflammatory responses and apoptosis.

Authors:  He Zhu; Jianshuai He; Jia Liu; Xin Zhang; Fengyun Yang; Pingting Liu; Shilei Wang
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-02

4.  Scavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cells.

Authors:  Angelia D Lockett; Daniela N Petrusca; Matthew J Justice; Christophe Poirier; Karina A Serban; Natalia I Rush; Malgorzata Kamocka; Dan Predescu; Sanda Predescu; Irina Petrache
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-19       Impact factor: 5.464

5.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

Review 6.  Alpha-1 Antitrypsin Investigations Using Animal Models of Emphysema.

Authors:  Kevin Ni; Karina A Serban; Chanan Batra; Irina Petrache
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 7.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

8.  α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α.

Authors:  Angelia D Lockett; Samuel Kimani; Godfrey Ddungu; Sabine Wrenger; Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

9.  Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines.

Authors:  Mila Ljujic; Sanja Mijatovic; Mirna Z Bulatovic; Marija Mojic; Danijela Maksimovic-Ivanic; Dragica Radojkovic; Aleksandra Topic
Journal:  Pathol Oncol Res       Date:  2016-09-12       Impact factor: 3.201

10.  Alpha-1 Antitrypsin and Lung Cell Apoptosis.

Authors:  Karina A Serban; Irina Petrache
Journal:  Ann Am Thorac Soc       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.